Stage IA vs. IB endometrial stromal sarcoma: Does the new staging system predict survival?

Gynecologic Oncology

Volumn 118, Issue 1, 2010, Pages 8-13

  Garg, G ^a   Shah, J P ^b   Toy, E P ^c   Bryant, C S ^b   Kumar, S ^a   Morris, R T ^b  

^a DETROIT MEDICAL CENTER   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Endometrial stromal sarcoma; Stage IA; Stage IB; Survival

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DATA EXTRACTION; DEMOGRAPHY; ENDOMETRIUM SARCOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; RISK ASSESSMENT; UTERINE CERVIX DISEASE;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SARCOMA, ENDOMETRIAL STROMAL; SEER PROGRAM; SURVIVAL RATE; UNITED STATES;

EID: 77953244168     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.04.008     Document Type: Article

References (22)

1. Harlow B.L., Weiss N.S., and Lofton S. The epidemiology of sarcomas of the uterus. J Natl Cancer Inst 76 (1986) 399-402
2. Kempson R.L., and Hendrickson M.R. Smooth muscle, endometrial stromal, and mixed Mullerian tumors of the uterus. Mod Pathol 13 (2000) 328-342
3. Hasiakos D., Papakonstantinou K., Kondi-Paphiti A., and Fotiou S. Low-grade endometrial stromal sarcoma of the endocervix. Report of a case and review of the literature. Eur J Gynaecol Oncol 28 (2007) 483-486
4. Tavassoli FA DP, editors. World Health Organization Classification of Tumors. Pathology and genetics of tumors of the breast and female genital organs. IARC Press: Lyon; 2003.
5. Evans H.L. Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma. Cancer 50 (1982) 2170-2182
6. Nordal R.R., Kristensen G.B., Kaern J., Stenwig A.E., Pettersen E.O., and Trope C.G. The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcoma. Gynecol Oncol 62 (1996) 254-259
7. De Fusco P.A., Gaffey T.A., Malkasian Jr. G.D., Long H.J., and Cha S.S. Endometrial stromal sarcoma: review of Mayo Clinic experience, 1945-1980. Gynecol Oncol 35 (1989) 8-14
8. Shah J.P., Bryant C.S., Kumar S., Ali-Fehmi R., Malone Jr. J.M., and Morris R.T. Lymphadenectomy and ovarian preservation in low-grade endometrial stromal sarcoma. Obstet Gynecol 112 (2008) 1102-1108
9. Mansi J.L., Ramachandra S., Wiltshaw E., and Fisher C. Endometrial stromal sarcomas. Gynecol Oncol 36 (1990) 113-118
10. Haberal A., Kayikcioglu F., Boran N., Caliskan E., Ozgul N., and Kose M.F. Endometrial stromal sarcoma of the uterus: analysis of 25 patients. Eur J Obstet Gynecol Reprod Biol 109 (2003) 209-213
11. Gadducci A., Sartori E., Landoni F., Zola P., Maggino T., Cosio S., et al. The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases. Eur J Gynaecol Oncol 23 (2002) 295-299
12. Prat J. FIGO staging for uterine sarcomas. Int J Gynaecol Obstet 104 (2009) 177-178
13. Chang K.L., Crabtree G.S., Lim-Tan S.K., Kempson R.L., and Hendrickson M.R. Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases. Am J Surg Pathol 14 (1990) 415-438
14. Surveillance E, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 17 Regs Limited-Use + Hurricane Katrina Impacted Louisiana Cases, Nov 2008 Sub (1973-2006 varying) - Linked To County Attributes - Total U.S., 1969-2006 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2009, based on the November 2008 submission.
15. Odicino F., Pecorelli S., Zigliani L., and Creasman W.T. History of the FIGO cancer staging system. Int J Gynaecol Obstet 101 (2008) 205-210
16. Abeler V.M., Royne O., Thoresen S., Danielsen H.E., Nesland J.M., and Kristensen G.B. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology 54 (2009) 355-364
17. Hachisuga T., Kaku T., Fukuda K., Eguchi F., Emoto M., Kamura T., et al. The grading of lymphovascular space invasion in endometrial carcinoma. Cancer 86 (1999) 2090-2097
18. Cirisano Jr. F.D., Robboy S.J., Dodge R.K., Bentley R.C., Krigman H.R., Synan I.S., et al. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma. Gynecol Oncol 77 (2000) 55-65
19. Bodner K., Bodner-Adler B., Obermair A., Windbichler G., Petru E., Mayerhofer S., Czerwenka K., et al. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients. Gynecol Oncol 81 (2001) 160-165
20. Li N., Wu L.Y., Zhang H.T., An J.S., Li X.G., and Ma S.K. Treatment options in stage I endometrial stromal sarcoma: a retrospective analysis of 53 cases. Gynecol Oncol 108 (2008) 306-311
21. Potosky A.L., Riley G.F., Lubitz J.D., Mentnech R.M., and Kessler L.G. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 31 (1993) 732-748
22. Warren J.L., Harlan L.C., Fahey A., Virnig B.A., Freeman J.L., Klabunde C.N., Cooper G.S., and Knopf K.B. Utility of the SEER-Medicare data to identify chemotherapy use. Med Care 40 (2002) IV-55-IV-61